AAV vector services
Flexible AAV production for early-stage teams.
Built for iteration, not lock-in.
Small-batch runs, decision-grade QC, and clean in vivo readouts without enterprise timelines or minimums.
What you get
- Batch sizes matched to your experiment cadence
- Fast iteration before enterprise scale
- Decision-grade QC without bureaucracy
- Direct access to scientists, not ticketing systems
The cost of unclear delivery
When signal is weak, you're left guessing: did the biology fail, or did delivery?
Experiment pain
- Weak or inconsistent in vivo expression
- Results hard to defend to stakeholders
- Repeated runs to validate delivery
Decision pain
- Delays moving to next experiments
- More spend before justifying scale
- Engineering time on workarounds, not biology
AAV as your in vivo baseline
AAV is well-characterized and review-friendly. We align scope and QC to your stage so you can learn fast and scale when ready.
Decision-grade QC
Characterization you can trust and act on.
Right-sized runs
Skip enterprise timelines while validating feasibility.
Reusable documentation
Outputs ready for collaborators or later partners.
Braiding Bio vs traditional CDMOs
Still optimizing construct, capsid, or dose? The fastest program is the one that can iterate.
| Factor | Traditional CDMO | Braiding Bio |
|---|---|---|
| Batch sizing | Fixed minimums | Matched to experiment cadence |
| Lead time | Queues and slotting | Faster starts, tighter loops |
| Mid-project changes | Change orders, re-queuing | Built for iteration |
| Communication | PM layers and tickets | Direct scientist access |
| Pricing | Enterprise campaigns | Early-stage friendly |
| Outputs | Compliance-forward | Decision-grade and reusable |
Get in touch
Email us at info@braidingbio.com or fill out the form below.
We'll respond within 24 hours.
What to include
- Construct length and key features
- Promoter and regulatory elements
- Target cell type and MOI range
- QC needs (titer, purity, sterility)
- Desired timeline